Pfizer Inc. (NYSE:PFE) Goldman Sachs 46th Annual Global Healthcare Conference June 9, 2025 8:00 AM ET
Company Participants
Albert Bourla – Chairman of the Board & CEO
Conference Call Participants
Asad Haider – Goldman Sachs Group, Inc., Research Division
Asad Haider
Great. Good morning, everyone, and welcome to our 46th Annual Global Healthcare Conference. My name is Asad Haider, I’m the U.S. pharma analyst here at Goldman Sachs and we are very privileged to have Albert Bourla with us to kick off this conference. Albert is the CEO of Pfizer. Albert, thank you for being with us.
Albert Bourla
Great pleasure.
Question-and-Answer Session
Asad Haider
Albert, we have about 35 minutes. So I want to start with a big picture question for you on the external environment, which I think is something that everyone is trying to figure out. You’re the perfect curtain raiser for this conference given your role as the Chair of the Pharma lobbying group, you have a very unique perspective and you have front row seats on what’s going on in Washington, D.C. with respect to policy and all these overhangs on the sector. So level set for us to kick the conversation off on where things stand in your most recent conversations with the administration, particularly as it relates to this drug pricing MFN executive order.
What should we be expecting to hear this week? I believe this week marks the 30-day mark from the time that the executive order was first put out. And what are the range of outcomes that the industry is expecting, both near term as well as how this plays out over the longer term?
Albert Bourla
Yes. Apparently, there is a lot of anxiety with investors, which is very obvious in the multiples of all the pharma that have been depressed to
#Pfizer #PFE #Presents #Goldman #Sachs #46th #Annual #Global #Healthcare #Conference #Transcript